Chantalle Briggs

Chantalle is an associate with Bereskin & Parr LLP. Her practice focuses on life sciences and medical device matters, including patents and related regulatory issues under the Food and Drugs Act.

Chantalle’s Ph.D. research was directed to the anatomical and electrophysiological regulation of sleep/wake behaviour, which she then pursued as a research associate in both Canada and Japan. She has authored and co-authored several publications on neuroscience and neuropharmacology, most recently Sleep deprivation-induced pre- and postsynaptic modulation of orexin neurons.

She has been involved in several science outreach initiatives such as Let’s Talk Science and the Canadian Medical Hall of Fame Discovery Days, and science policy organizations including a term as national program coordinator for Evidence for Democracy. In September 2022, Chantalle joined the Executive of the Canadian Bar Association’s Health Law Section as a Member-at-Large.

Chantalle is fluent in English and French.